Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
BIOX Stock Forecast 2026-2027
$0.42
Current Price
$26.80M
Market Cap
Buy 0
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to BIOX Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
BIOX Price Momentum
0.0%
1 Week Change
-6.7%
1 Month Change
-90.4%
1 Year Change
-67.9%
Year-to-Date Change
-91.8%
From 52W High of $5.15
+21.0%
From 52W Low of $0.35
📊 TOP ANALYST CALLS
Did BIOX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Bioceres is one of their latest high-conviction picks.
Latest BIOX Stock Price Targets & Analyst Predictions
BIOX has shown a year-to-date change of -67.9% and a 1-year change of -90.4%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for BIOX. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
BIOX Analyst Ratings
0
Buy
1
Hold
0
Sell
BIOX Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.42
Latest BIOX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for BIOX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 2, 2026 | Canaccord Genuity | Austin Moeller | Hold | Maintains | $2.00 |
| Nov 14, 2025 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Sep 10, 2025 | Lake Street | Buy | Maintains | $N/A | |
| Sep 10, 2025 | Canaccord Genuity | Hold | Downgrade | $N/A | |
| Jul 15, 2025 | Oppenheimer | Outperform | Maintains | $N/A | |
| Apr 22, 2025 | Oppenheimer | Outperform | Maintains | $N/A | |
| Feb 13, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Feb 7, 2025 | Lake Street | Buy | Maintains | $N/A | |
| Feb 7, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Jan 28, 2025 | Oppenheimer | Outperform | Maintains | $N/A | |
| Nov 13, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Oct 21, 2024 | Oppenheimer | Outperform | Maintains | $N/A | |
| Oct 17, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Sep 11, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Sep 11, 2024 | Roth MKM | Buy | Maintains | $N/A | |
| Sep 11, 2024 | Lake Street | Buy | Maintains | $N/A | |
| Sep 11, 2024 | Oppenheimer | Outperform | Maintains | $N/A | |
| Jul 19, 2024 | Canaccord Genuity | Austin Moeller | Buy | Assumes | $17.00 |
| Jul 2, 2024 | Roth MKM | Scott Fortune | Buy | Reinstates | $15.00 |
| Feb 9, 2024 | Roth MKM | Buy | Maintains | $N/A |
Bioceres Crop Solutions Corp. (BIOX) Competitors
The following stocks are similar to Bioceres based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Bioceres Crop Solutions Corp. (BIOX) Financial Data
Bioceres Crop Solutions Corp. has a market capitalization of $26.80M with a P/E ratio of 227.0x. The company generates $255.21M in trailing twelve-month revenue with a -96.9% profit margin.
Revenue growth is -35.9% quarter-over-quarter, while maintaining an operating margin of -12.6% and return on equity of -32.2%.
Valuation Metrics
Market Cap
$26.80M
Enterprise Value
$279.71M
P/E Ratio
227.0x
PEG Ratio
0.4x
Price/Sales
0.1x
Growth & Margins
Revenue Growth (YoY)
-35.9%
Gross Margin
+33.2%
Operating Margin
-12.6%
Net Margin
-96.9%
EPS Growth
-35.9%
Financial Health
Cash/Price Ratio
+55.7%
Current Ratio
0.9x
Debt/Equity
251.0x
ROE
-32.2%
ROA
-0.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Bioceres Crop Solutions Corp. (BIOX) Business Model
About Bioceres Crop Solutions Corp.
What They Do
Develops innovative solutions for crop productivity.
Business Model
Bioceres Crop Solutions generates revenue through the commercialization of a diverse portfolio of agricultural products and services, including seed technologies, crop nutrition, and protection solutions. Their business model focuses on enhancing crop yield and sustainability, which is increasingly important in a market that demands higher efficiency and resilience in food production.
Additional Information
The company is actively involved in biotechnological research and development, aiming to improve crop resilience against climate challenges. By forming partnerships and collaborations, Bioceres expands its influence in global agricultural markets, positioning itself as a significant player in sustainable agriculture.
Company Information
Sector
Basic Materials
Industry
Agricultural Inputs
Employees
751
CEO
Dr. Federico Trucco Ph.D.
Country
Argentina
IPO Year
N/A
Bioceres Crop Solutions Corp. (BIOX) Latest News & Analysis
Latest News
Quick Summary
Bioceres Crop Solutions Corp. (BIOX) held its Q3 2026 earnings call, discussing financial performance and strategic initiatives. Further details on earnings will be available in the full transcript.
Why It Matters
The Q3 2026 earnings call for Bioceres Crop Solutions Corp. provides insights into financial performance, growth potential, and market positioning, influencing investment decisions and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results
1 month ago
Quick Summary
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) released its fiscal Q3 financial results for the period ending March 31, 2026, focusing on solutions for resilient agriculture in climate change.
Why It Matters
Bioceres’ financial results indicate its performance and growth potential in sustainable agriculture, impacting investor sentiment and stock valuation in the agtech sector.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Bioceres Crop (BIOX) reported a quarterly loss of $0.16 per share, worse than the expected loss of $0.05, and a decline from a loss of $0.02 per share a year earlier.
Why It Matters
Bioceres Crop's larger-than-expected quarterly loss signals weaker performance, potentially impacting investor confidence and stock value.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Bioceres Crop Solutions (NASDAQ: BIOX) will host its fiscal Q3 2026 financial results conference call on May 12, 2026, at 8:30 AM ET. Updated dial-in details provided.
Why It Matters
Accurate conference call details are crucial for investors to access financial results and insights, influencing their investment decisions regarding Bioceres Crop Solutions.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will hold a conference call on May 12, 2026, at 8:30 a.m. ET to discuss Q3 fiscal results for the period ending March 31, 2026.
Why It Matters
Bioceres Crop Solutions' upcoming earnings call and results release can significantly impact investor sentiment and stock performance, reflecting the company's growth and climate resilience strategies.
Source: Business Wire
Market Sentiment:
Neutral
A Message from Our Chief Executive Officer
2 months ago
Quick Summary
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) has filed its Form 6-K for Q2 FY 2026, covering the six months ended December 31, 2025, detailing its business focus and current challenges.
Why It Matters
Bioceres Crop Solutions' update indicates strategic focus and transparency amidst challenges, potentially impacting investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About BIOX Stock
What is Bioceres Crop Solutions Corp.'s (BIOX) stock forecast for 2026?
Analyst forecasts for Bioceres Crop Solutions Corp. (BIOX) are not currently available. The stock is trading at $0.42.
Is BIOX stock a good investment in 2026?
According to current analyst ratings, BIOX has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.42. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for BIOX stock?
Price predictions from Wall Street analysts for BIOX are not currently available. The stock is trading at $0.42.
What is Bioceres Crop Solutions Corp.'s business model?
Bioceres Crop Solutions generates revenue through the commercialization of a diverse portfolio of agricultural products and services, including seed technologies, crop nutrition, and protection solutions. Their business model focuses on enhancing crop yield and sustainability, which is increasingly important in a market that demands higher efficiency and resilience in food production.
What is the highest forecasted price for BIOX Bioceres Crop Solutions Corp.?
Price targets from Wall Street analysts for BIOX are not currently available. The stock is trading at $0.42.
What is the lowest forecasted price for BIOX Bioceres Crop Solutions Corp.?
Price targets from Wall Street analysts for BIOX are not currently available. The stock is trading at $0.42.
What is the overall BIOX consensus from analysts for Bioceres Crop Solutions Corp.?
The overall analyst consensus for BIOX is neutral. Out of 3 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell.
How accurate are BIOX stock price projections?
Stock price projections, including those for Bioceres Crop Solutions Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 14, 2026 5:19 AM UTC